News Releases
Drinking Water Recalled Due to Allergen Risk
Austin, TX – H-E-B has issued a voluntary recall specifically for the Hill Country Fare One Gallon Spring Water with the Best By date of December 19, 2015, due to the possible presence of a milk allergen.
Alcon Receives FDA Approval of Pazeo Solution for Ocular Allergy Itch Relief
Alcon, the global leader in eye care and a division of Novartis, has received approval from the U.S. Food and Drug Administration (FDA) of Pazeo™ (olopatadine hydrochloride ophthalmic solution) 0.7%, for the treatment of ocular itching associated with allergic conjunctivitis.
FDA Approves Treatment for Children With Allergic Rhinitis
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) announced today that the U.S. Food and Drug Administration (FDA) approved QNASL® (beclomethasone dipropionate) 40 mcg for the treatment of nasal symptoms associated with allergic rhinitis (AR) in children 4-11 years of age.
Undeclared Eggs Lead to Allergy Alert on Snack
Seoul Shik Poom Inc. of Englewood, NJ is recalling Choripdong Chocolate Almond Richmond Ice Bar (4bags/432ml) because they may contain undeclared eggs.
FDA Approves New Rx for Grass Pollen-Induced Allergic Rhinitis
The FDA has approved a new medication for those with symptoms caused by grass pollen allergy.
Greer Announces FDA Approval of Oralair for Grass Pollen Allergy
The FDA has approved a new medication to treat grass pollen allergies.
Allergic Rhinitis Rx in FDA Review Process
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today issued the following statement.
Allergy Medication Reduces Symptoms
Merck announced the results from a Phase III clinical study of its investigational allergy immunotherapy tablet ( AIT ) for ragweed pollen.